Loraz and Skin toxicity - a phase IV clinical study of FDA data

Summary:

Skin toxicity is reported as a side effect among people who take Loraz (lorazepam), especially for people who are male, 60+ old, also take Fentanyl, and have Cervix carcinoma.

The phase IV clinical study analyzes which people have Skin toxicity when taking Loraz. It is created by eHealthMe based on reports of 161,700 people who have side effects when taking Loraz from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Skin toxicity?

Skin toxicity (skin damage due to toxin/poison) is found to be associated with 269 drugs and 375 conditions by eHealthMe. Check the latest studies of Skin toxicity.

On Jul, 15, 2026

161,700 people reported to have side effects when taking Loraz.
Among them, 23 people (0.01%) have Skin toxicity.

Among these 23 people:

What is the gender of people who have Skin toxicity when taking Loraz? *

female: 45 %
male: 55 %

What is the age of people who have Skin toxicity when taking Loraz? *

What are other drugs people take besides Loraz? *

What are other side effects people have besides Skin toxicity? *

Febrile Neutropenia (fever with reduced white blood cells): 5 people, 21.74%
Abdominal Pain: 4 people, 17.39%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 17.39%
Thrombocytopenia (decrease of platelets in blood): 4 people, 17.39%
Diarrhea: 4 people, 17.39%
Mood Swings (an extreme or rapid change in mood): 3 people, 13.04%
Itching: 3 people, 13.04%
Weakness: 3 people, 13.04%
Heart Rate Increased: 3 people, 13.04%
Groin Pain: 3 people, 13.04%

What are the existing conditions these people have? *

Cervix Carcinoma (cancer of cervix): 5 people, 21.74%
Gastric Disorder (disease of stomach): 3 people, 13.04%
Malignant Melanoma (skin cancer rises from melancytes): 3 people, 13.04%
Back Pain: 3 people, 13.04%
Lung Adenocarcinoma Stage Iv (the cancer has spread to other organs of the body, such as the other lung, brain, or liver): 3 people, 13.04%
Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 3 people, 13.04%
Fever: 2 people, 8.70%
Breast Cancer: 2 people, 8.70%
Colon Cancer: 2 people, 8.70%
Tension Headache: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and have Skin toxicity?

- Check whether Skin toxicity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Loraz:

Loraz (165,694 reports)

Skin toxicity treatments and more:

Skin toxicity (5,295 reports)

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin toxicity:

Skin toxicity (269 drugs)

Browse all the conditions that are associated with Skin toxicity:

Skin toxicity (375 conditions)

Related publications that referenced our studies

Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam (the active ingredients of Loraz) and Loraz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.